Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and N-Acetylneuraminic acid: Difference between pages
(Difference between pages)
Content deleted Content added
Saving copy of the {{chembox}} taken from revid 453568185 of page N-Acetylneuraminic_acid for the Chem/Drugbox validation project (updated: 'ChEBI'). |
Innerstream (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
⚫ | |||
{{ambox | text = This page contains a copy of the infobox ({{tl|chembox}}) taken from revid [{{fullurl:N-Acetylneuraminic_acid|oldid=453568185}} 453568185] of page [[N-Acetylneuraminic_acid]] with values updated to verified values.}} |
|||
{{Chembox |
{{Chembox |
||
| Watchedfields = changed |
|||
| verifiedrevid = |
| verifiedrevid = 462257046 |
||
⚫ | |||
| |
| Name =''N''-Acetylneuraminic acid |
||
| ImageFile = Neu5Ac_in_neutral_form%2C_2C5_conformation.png |
|||
| ImageName = β anomer |
|||
| ImageSize = |
| ImageSize = |
||
| IUPACName = 5-( |
| IUPACName = 5-(Acetylamino)-3,5-dideoxy-<small>D</small>-''glycero''-α-<small>D</small>-''galacto''-non-2-ulopyranosonic acid |
||
| OtherNames = |
| OtherNames = {{ubl |
||
| NANA |
|||
⚫ | |||
| Neu5Ac |
|||
⚫ | |||
| Aceneuramic acid |
|||
⚫ | |||
| Acenobel}} |
|||
⚫ | |||
| CASNo_Ref = {{cascite|correct|CAS}} |
|||
⚫ | |||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = GZP2782OP0 |
|||
| ChEBI_Ref = {{ebicite|correct|EBI}} |
|||
⚫ | |||
| PubChem = 439197 |
| PubChem = 439197 |
||
| KEGG = D11016 |
|||
| |
| SMILES = OC(=O)[C@@]1(O)C[C@H](O)[C@@H](NC(C)=O)[C@@H](O1)[C@H](O)[C@H](O)CO |
||
| |
| MeSHName = N-Acetylneuraminic+Acid |
||
| |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
||
| ChemSpiderID = 392681 |
| ChemSpiderID = 392681 |
||
| |
| InChI = 1/C11H19NO9/c1-4(14)12-7-5(15)2-11(20,10(18)19)21-9(7)8(17)6(16)3-13/h5-9,13,15-17,20H,2-3H2,1H3,(H,12,14)(H,18,19)/t5-,6+,7+,8+,9+,11+/m0/s1 |
||
| |
| InChIKey = SQVRNKJHWKZAKO-YRMXFSIDBI |
||
| |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChI = 1S/C11H19NO9/c1-4(14)12-7-5(15)2-11(20,10(18)19)21-9(7)8(17)6(16)3-13/h5-9,13,15-17,20H,2-3H2,1H3,(H,12,14)(H,18,19)/t5-,6+,7+,8+,9+,11+/m0/s1 |
| StdInChI = 1S/C11H19NO9/c1-4(14)12-7-5(15)2-11(20,10(18)19)21-9(7)8(17)6(16)3-13/h5-9,13,15-17,20H,2-3H2,1H3,(H,12,14)(H,18,19)/t5-,6+,7+,8+,9+,11+/m0/s1 |
||
| |
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChIKey = SQVRNKJHWKZAKO-YRMXFSIDSA-N |
| StdInChIKey = SQVRNKJHWKZAKO-YRMXFSIDSA-N |
||
}} |
}} |
||
| |
|Section2={{Chembox Properties |
||
|C=11|H=19|N=1|O=9 |
| C=11 | H=19 | N=1 | O=9 |
||
⚫ | |||
| MolarMass = 309.273 g/mol |
|||
⚫ | |||
| ExactMass = 309.105981 |
|||
| MeltingPtC = 186 |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
}} |
}} |
||
| |
|Section3={{Chembox Pharmacology |
||
| |
| ATCCode_prefix = M09 |
||
| |
| ATCCode_suffix = AX05 |
||
⚫ | |||
| Autoignition = |
|||
}} |
}} |
||
|Section4={{Chembox Hazards |
|||
| MainHazards = |
|||
⚫ | |||
| AutoignitionPt = |
|||
}} |
|||
}} |
}} |
||
'''''N''-Acetylneuraminic acid''' ('''Neu5Ac''' or '''NANA''') is the predominant [[sialic acid]] found in human cells, and many mammalian cells. Other forms, such as [[N-Glycolylneuraminic acid]], may also occur in cells. |
|||
This residue is negatively charged at physiological pH and is found in complex [[glycans]] on [[mucin]]s and glycoproteins found at the [[cell membrane]]. Neu5Ac residues are also found in glycolipids, known as [[ganglioside]]s, a crucial component of neuronal membranes found in the [[brain]]. |
|||
Along with involvement in preventing infections ([[mucus]] associated with [[mucous membrane]]s—mouth, nose, GI, respiratory tract), Neu5Ac acts as a receptor for [[influenza]] viruses, allowing attachment to mucous cells via [[hemagglutinin]] (an early step in acquiring influenzavirus infection). |
|||
==In the biology of bacterial pathogens== |
|||
Neu5Ac is also important in the biology of a number of pathogenic and symbiotic bacteria<ref name=Severi2006>{{cite journal | vauthors = Severi E, Hood DW, Thomas GH | year = 2007 | title = Sialic acid utilization by bacterial pathogens | journal = Microbiology | volume = 153 | issue = 9| pages = 2817–2822 | pmid = 17768226 | doi=10.1099/mic.0.2007/009480-0| doi-access = free }}</ref><ref>{{Cite journal |last1=Vimr |first1=Eric R. |last2=Kalivoda |first2=Kathryn A. |last3=Deszo |first3=Eric L. |last4=Steenbergen |first4=Susan M. |date=March 2004 |title=Diversity of Microbial Sialic Acid Metabolism |journal=Microbiology and Molecular Biology Reviews |volume=68 |issue=1 |pages=132–153 |doi=10.1128/MMBR.68.1.132-153.2004 |issn=1092-2172 |pmid=15007099|pmc=362108 }}</ref><ref name=Vimr2004>{{cite journal | vauthors = Vimr ER, Kalivoda KA, Deszo EL, Steenbergen SM | year = 2004 | title = Diversity of microbial sialic acid metabolism. | journal = Microbiol Mol Biol Rev | volume = 68 | issue = 1| pages = 132–153 | pmid = 15007099 | pmc=362108 | doi=10.1128/mmbr.68.1.132-153.2004}}</ref> as it can be used either as a nutrient, providing both carbon and nitrogen to the bacteria, or in some pathogens, can be activated and placed on the cell surface.<ref name=Severi2006 /> Bacteria have evolved transporters for Neu5Ac to enable them to capture it from their environment and a number of these have been characterized including the NanT protein from ''[[Escherichia coli]]'',<ref name=Vimr1985>{{cite journal |vauthors = Vimr ER, Troy FA |year = 1985 |title = Identification of an inducible catabolic system for sialic acids (nan) in Escherichia coli |journal = J. Bacteriol. |volume = 164 |issue = 2|pages = 845–853 |doi = 10.1128/jb.164.2.845-853.1985 |pmid = 3902799 |pmc=214328}}</ref> the SiaPQM [[Tripartite ATP-independent periplasmic transporter|TRAP]] transporter from ''[[Haemophilus influenzae]]''<ref name=Severi2005>{{cite journal| vauthors = Severi E, Randle G, Kivlin P, Whitfield K, Young R, Moxon R, Kelly D, Hood D, Thomas GH |year = 2005 |title = Sialic acid transport in Haemophilus influenzae is essential for lipopolysaccharide sialylation and serum resistance and is dependent on a novel tripartite ATP-independent periplasmic transporter|journal = Mol. Microbiol.|volume = 58|issue=4|pages = 1173–1185|pmid = 16262798|doi=10.1111/j.1365-2958.2005.04901.x|s2cid = 32085592 |doi-access = free}}</ref> and the SatABCD [[ABC transporter]] from ''[[Haemophilus ducreyi]]''.<ref name=Post2005>{{cite journal | vauthors = Post DM, Mungur R, Gibson BW, ((Munson RS Jr)) | year = 2005 | title = Identification of a novel sialic acid transporter in Haemophilus ducreyi. | journal = Infect Immun | volume = 73 | issue = 10| pages = 6727–35 | pmid = 16177350 | doi=10.1128/IAI.73.10.6727-6735.2005 | pmc=1230923}}</ref> |
|||
==Medical use== |
|||
In Japan, Neu5Ac is approved under the trade name Acenobel for the treatment of [[distal myopathy with rimmed vacuoles]].<ref>{{cite web | url = https://www.nobelpharma.co.jp/_cms/wp-content/uploads/2024/03/587fe2db53b3944fb58405e11716b6d1.pdf | title = “ACENOBEL® Sustained Release Tablet 500 mg” Approved for Distal Myopathy with Rimmed Vacuoles | publisher = Nobelpharm }}</ref> |
|||
==See also== |
|||
* [[Neuraminic acid]] |
|||
* [[N-Glycolylneuraminic acid|''N''-Glycolylneuraminic acid]] |
|||
* [[Sialic acid]] |
|||
== References == |
|||
{{reflist|2}} |
|||
{{Other drugs for disorders of the musculo-skeletal system}} |
|||
{{Authority control}} |
|||
{{DEFAULTSORT:Acetylneuraminic Acid, N-}} |
|||
[[Category:Amino sugars]] |
|||
[[Category:Sugar acids]] |
|||
[[Category:Monosaccharides]] |